The company is leaning on its subcutaneous technology to deliver long-acting options that could prevent patients from cycling through drugs.

FDA recently announced new safety requirements for DPD screening in cancer patients. Kristine Ashcraft, founder and CEO of ...

European STOXX Europe 600 Index experienced a modest rise, reflecting investor sentiment shaped by U.S. trade policy developments and geopolitical efforts to resolve the Russia-Ukraine conflict. In ...